Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2020 / N 4

Терапия хронической ишемии мозга на фоне гипертонической болезни: препараты выбора
О.А. Лиманова, О.А. Громова, Л.Э. Федотова

References

1. Gusev EI, Skvortsova VI. Brain ischemia. Moscow: Meditsina; 2001. 326 p. (In Russian).
2. Lokshina AB, Zakharov VV. Practical algorithms for managing patients with chronic cerebral ischemia. Effective Pharmacotherapy 2019;15(19):26-30 (In Russian).
3. Vorobyova OV. Chronic brain ischemia: from pathogenesis to therapy: guidelines to an outpatient neurologist. Russian Medical Journal 2018;2(5):26-31 (In Russian).
4. Rachin AP, Vygovskaya SN, Nuvakhova MB, Doroghinina AYu. Chronic brain ischemia – from correct diagnosis to adequate therapy. Russian Medical Journal 2015;23(12):694-8 (In Russian).
5. Gauthier S, Touchon J. Subclassification of mild cognitive impairment in research and in clinical practice. In: Alzheimer’s disease and related disorders. Annual 2004. Gauthier S, Scheltens P, Cummings JL, editors. New York: Taylor & Frances; 2004: 61-9.
6. Regier DA, Kuhl EL, Kupfer DJ. DSM-5: Классификация и изменения критериев. World Psychiatry 2013 Jun;12(2):88-94.
7. Levin OS. Dyscirculatory encephalopathy: current ideas about development mechanisms and treatment. Consilium Medicum 2006;8(8):72-9 (In Russian).
8. Yakhno NN, Levin OS, Damulin IV. Comparison of clinical and MRI data in dyscirculatory encephalopathy. Message 2: cognitive impairment. Neurological Journal 2001;6(3):10-8 (In Russian).
9. Vereshchagin NV, Morgunov VA, Gulevskaya TS. Brain pathology in atherosclerosis and arterial hypertension. Moscow: Meditsina; 1997. 288 p. (In Russian).
10. Kotova OV, Akarachkova ES. Chronic cerebral ischemia: pathogenetic mechanisms and treatment principles. Farmateka 2010;8(202):57-61 (In Russian).
11. Sorokina IB. Pathogenetic directions of therapy of chronic cerebrovascular insufficiency. Medical Council 2011;3-4:101-3 (In Russian).
12. Russian Medical Society on Arterial Hypertension; Russian Society of Cardiologists. Diagnosis and treatment of arterial hypertension. Russian recommendations. 4th revision. Moscow, 2010. 34 p. (In Russian).
13. Kobalava ZhD, Kolesnik VL, Troitskaya EA. Current European guidelines on arterial hypertension: updated positions and unresolved issues. Klinicheskaya Farmakologiya i Terapiya 2019;28(2):7-17 (In Russian).
14. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002 Apr;58(8):1175-81.
15. Markin SP. Current approach to diagnosis and treatment of chronic brain ischemia. Russian Medical Journal 2010;18(8):445-50 (In Russian).
16. Parfenov VA, Verbitskaya SV, Starchenko YuA. Antihypertensive therapy-based secondary prevention of ischemic stroke. Neurology, Neuropsychology, Psychosomatics 2012;1:96-101 (In Russian).
17. Preobrazhenskiy DV, Sidorenko BA, Batyraliyev TA. ACE inhibitors and AT1-blockers in clinical practice. Part 1. Moscow, 2002. 224 p. (In Russian).
18. Sidorenko BA, Savchenko MV, Preobrazhenskiy DV. Angiotensin converting enzyme inhibitors in treatment of hypertension. Kardiologiia 2000;2:74-82 (In Russian).
19. Mancia G, Omboni S; IPSIS Group. Antihypertensive efficacy of amlodipine vs fosinopril as assessed by 48-hour ambulatory blood pressure monitoring in isolated systolic hypertension. In: Seventh European Meeting on Hypertension; 1995 Jun 9-12; Milan, Italy: European Society of Hypertension; 1995. Abstract 501.
20. Vauquelin G, Fierens FL, Verheijen I, Vanderheyden PM. Distinctions between non-peptide angiotensin II AT1-receptor antagonists. Journal of the Renin-Angiotensin-Aldosterone-System 2001 Mar;2(Suppl 1):S24-31.
21. Unger T. Differences among angiotensin II type 1 receptor blockers: characterization of candesartan cilexetil. Blood Pressure. Supplement 2000;1:14-8.
22. Gulhrie GP Jr. Angiotensin receptors: physiology and pharmacology. Clinical Cardiology 1995 Jun;18(Suppl 3):29-34.
23. Preobrazhenskiy DV, Sidorenko BA. Side effects of AT1-angiotensin receptor blockers. Kardiologiia 2002;3:88-94 (In Russian).
24. O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. The Lancet. Neurology 2003 Feb;2:289-98.
25. Tanashyan MM, Barkhatov DYu. Metabolic therapy in neurology: new approaches. Russian Medical Journal 2011;20(8):406-8 (In Russian).
26. Kamchatnov PR, Yevzelman MA, Morozova YuA. Prospects of combined therapy in patients with chronic cerebral circulation disorders. Poliklinika 2017;2-2:73-8 (In Russian).
27. Zakharov VV. Vinpotropil in treatment of dyscirculatory encephalopathy and cognitive impairments without dementia. SS Korsakov Journal of Neurology and Psychiatry 2010;110(11):13-6 (In Russian).
28. Kamchatnov PR. Chronic cerebral circulation disorders and metabolic therapy. Russian Medical Journal 2008;16(5):274-6 (In Russian).
29. Gromova OA, Torshin IYu, Kalacheva AG. Triple synergism of ethylmethylhydroxypyridine succinate, magnesium and vitamin B6: molecular mechanisms. Neurology, Neuropsychology, Psychosomatics 2017;9(1):42-9 (In Russian).
30. Gromova OA, Torshin IYu, Fedotova LE, Gromov AI. Chemoreactomic analysis of ethylmethylpyridine succinate. Neurology, Neuropsychology, Psychosomatics 2016;8(3):53-60 (In Russian).
31. Torshin IY, Gromova OA. Magnesium and pyridoxine: fundamental studies and clinical practice. New York: Nova Science Publishers; 2011. 196 p.
32. Malouf R, Evans JG. The effect of vitamin B6 on cognition. The Cochrane Database of Systematic Reviews 2003;(4):СD004393.
33. Gao Z, Thang H, Liu J, Lau SW, Liu P, Chen ZY, Lee HK, Tipoe GL, Ho HM, Yao X, Huang Y. Cyclooxygenace-2-dependent oxidative stress mediates palmitate-induced impartment of endothelium-dependent relaxations in mouse arteries. Biochemical Pharmacology 2014 Oct;91(4):471-82.
  

[ Содержание выпуска N 4 | Выпуски журнала | Список журналов ]